Opaleye Management as of Sept. 30, 2021
Portfolio Holdings for Opaleye Management
Opaleye Management holds 48 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ocular Therapeutix (OCUL) | 12.1 | $65M | 6.5M | 10.00 | |
| Celldex Therapeutics Com New (CLDX) | 9.9 | $53M | 985k | 53.85 | |
| Codexis (CDXS) | 5.8 | $31M | 1.3M | 23.26 | |
| Chimerix (CMRX) | 5.8 | $31M | 5.0M | 6.19 | |
| Harrow Health (HROW) | 5.6 | $30M | 3.3M | 9.09 | |
| Semler Scientific (SMLR) | 5.3 | $28M | 226k | 125.03 | |
| Bridgebio Pharma (BBIO) | 4.5 | $24M | 512k | 46.87 | |
| Cytokinetics Com New (CYTK) | 3.9 | $21M | 580k | 35.74 | |
| Protara Therapeutics Com Stk (TARA) | 3.3 | $18M | 2.6M | 6.92 | |
| Eton Pharmaceuticals (ETON) | 2.9 | $16M | 3.1M | 5.04 | |
| Kiniksa Pharmaceuticals Com Cl A | 2.8 | $15M | 1.3M | 11.39 | |
| Keros Therapeutics (KROS) | 2.6 | $14M | 353k | 39.56 | |
| Stereotaxis Com New (STXS) | 2.5 | $14M | 2.5M | 5.38 | |
| Fortress Biotech | 2.3 | $12M | 3.8M | 3.22 | |
| Proqr Therapeutics Nv Shs Euro (PRQR) | 2.2 | $12M | 1.4M | 8.37 | |
| Sutro Biopharma (STRO) | 1.9 | $10M | 538k | 18.89 | |
| Tracon Pharmaceuticals Com New | 1.8 | $9.7M | 2.5M | 3.87 | |
| Macrogenics (MGNX) | 1.8 | $9.7M | 462k | 20.94 | |
| Larimar Therapeutics (LRMR) | 1.8 | $9.6M | 833k | 11.53 | |
| Vaxcyte (PCVX) | 1.7 | $9.0M | 353k | 25.37 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.6 | $8.5M | 402k | 21.05 | |
| Xoma Corp Del Com New (XOMA) | 1.6 | $8.4M | 338k | 24.75 | |
| Neoleukin Therapeutics | 1.4 | $7.6M | 1.0M | 7.23 | |
| Adamas Pharmaceuticals | 1.3 | $7.2M | 1.5M | 4.91 | |
| Verastem | 1.3 | $7.2M | 2.3M | 3.08 | |
| Deciphera Pharmaceuticals | 1.3 | $7.0M | 205k | 33.98 | |
| Tela Bio (TELA) | 1.1 | $6.1M | 443k | 13.66 | |
| Protagonist Therapeutics (PTGX) | 1.1 | $5.9M | 330k | 17.72 | |
| Acutus Medical (AFIB) | 1.0 | $5.2M | 590k | 8.84 | |
| Optinose (OPTN) | 0.9 | $4.7M | 1.6M | 3.00 | |
| Mei Pharma Com New | 0.8 | $4.3M | 1.6M | 2.76 | |
| Forma Therapeutics Holdings SHS | 0.8 | $4.2M | 183k | 23.19 | |
| Sierra Oncology Com New | 0.7 | $3.6M | 166k | 21.92 | |
| Avalo Therapeutics | 0.6 | $3.2M | 1.5M | 2.18 | |
| Amicus Therapeutics (FOLD) | 0.6 | $3.1M | 321k | 9.55 | |
| Aveo Biosciences Com New | 0.5 | $2.8M | 456k | 6.18 | |
| Merus N V (MRUS) | 0.4 | $2.2M | 100k | 22.00 | |
| Viracta Therapeutics (VIRX) | 0.4 | $2.1M | 259k | 8.02 | |
| Sio Gene Therapies Common | 0.4 | $2.1M | 955k | 2.17 | |
| Leap Therapeutics | 0.4 | $1.9M | 476k | 4.01 | |
| Precision Biosciences Ord | 0.4 | $1.9M | 164k | 11.54 | |
| Aadi Bioscience (AADI) | 0.2 | $1.3M | 45k | 29.36 | |
| Nucana Sponsored Adr | 0.2 | $1.2M | 480k | 2.58 | |
| Aptose Biosciences Com New | 0.2 | $1.2M | 549k | 2.18 | |
| Akebia Therapeutics (AKBA) | 0.2 | $897k | 311k | 2.88 | |
| Selecta Biosciences | 0.1 | $441k | 106k | 4.16 | |
| Cymabay Therapeutics | 0.1 | $420k | 115k | 3.65 | |
| Biolinerx Sponsored Ads (BLRX) | 0.0 | $46k | 17k | 2.76 |
